WRBY - NYSE

Warby Parker Inc.

WRBY·NYSE

$24.22

-0.0021%

HealthcareMedical - Instruments & Supplies

Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.97B

EPS0.0134

P/E Ratio1807.46

Earnings Date08/06/2026

720.92M

Assets

3Y+27.0%

5Y+62.0%

10Y+310.0%

353.19M

Total Liabilities

3Y+25.0%

5Y+159.0%

10Y+245.0%

367.73M

Total Equity

3Y+28.0%

5Y+19.0%

10Y+401.0%

Warby Parker Inc. Funding & Solvency Profile

WRBY · NYSE

Current Assets

Cash & Cash Equivalents286.36M

Net Receivables3.29M

Inventory44.51M

Other Current Assets18.28M

Total Current Assets352 M

Non-Current Assets

Property, Plant & Equipment358.25M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets10.23M

Total Non-Current Assets368 M

Total Assets

720.92M

Financial Health Analysis

Current Ratio

2.35x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.96x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

202 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

49% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Warby Parker Inc. Balance Sheet

WRBY • NYSE

Warby Parker Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	286.4M	254.2M	216.9M	208.6M	256.4M	314.1M	55.4M
Cash & Short-Term Investments	286.4M	254.2M	216.9M	208.6M	256.4M	314.1M	55.4M
Net Receivables	3.3M	1.9M	1.8M	1.4M	992K	601K	1.1M
Accounts Receivables	3.3M	1.9M	1.8M	1.4M	992K	601K	1.1M
Inventory	44.5M	52.3M	62.2M	68.8M	57.1M	38.5M	28.4M
Prepaids	0.0	0.0	0.0	0.0	13.5M	6.8M	6.7M
Other Current Assets	18.3M	17.6M	17.7M	15.7M	0.0	0.0	0.0
Total Current Assets	352.4M	326M	298.6M	294.6M	328M	359.9M	91.7M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	358.3M	341.7M	274.6M	265.6M	112.2M	84.5M	83.9M
Intangible Assets	0.0	0.0	0.0	0.0	8.6M	3.6M	3.7M
Goodwill & Intangible Assets	0.0	0.0	0.0	0.0	8.6M	3.6M	3.7M
Long-Term Investments	0.0	2M	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	10.2M	6.7M	7.1M	8.5M	-8.1M	-3.3M	-3.4M
Total Non-Current Assets	368.5M	350.4M	281.7M	274.1M	112.7M	84.8M	84.2M
Total Assets	720.9M	676.5M	580.3M	568.7M	440.6M	444.8M	175.9M
LIABILITIES
CURRENT LIABILITIES
Total Payables	32M	23.5M	22.5M	20.8M	30.9M	40.8M	37.3M
Accounts Payable	32M	23.5M	22.5M	20.8M	30.9M	40.8M	37.3M
Accrued Expenses	0.0	0.0	46.3M	58.2M	11.9M	7.9M	3.7M
Short Term Debt	31.4M	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	20.2M	24.3M	22.5M	0.0	0.0	0.0
Deferred Revenue	33.9M	32.4M	31.6M	25.6M	22.1M	26.6M	19.2M
Other Current Liabilities	52.9M	54.2M	2.4M	2.4M	53.3M	30.1M	15.6M
Total Current Liabilities	150.1M	130.4M	127.1M	129.6M	118.1M	105.3M	75.9M
NON-CURRENT LIABILITIES
Long Term Debt	201.7M	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	1.3M	943K	1.3M	1.7M	36.5M	31M	26.6M
Total Non-Current Liabilities	203.1M	206.1M	151.4M	152.5M	36.5M	31M	26.6M
Capital Lease Obligations	0.0	225.4M	174.5M	173.4M	0.0	0.0	0.0
Total Liabilities	353.2M	336.4M	278.5M	282.1M	154.6M	136.3M	102.5M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	506.5M	262.8M
Common Stock	12K	12K	12K	12K	11K	5K	5K
Additional Paid-In Capital	0.0	1B	970.1M	890.9M	779.2M	127.2M	80M
Retained Earnings	-685.6M	-687.2M	-666.8M	-603.6M	-493.2M	-325.4M	-269.5M
Accumulated Other Comprehensive Income/Loss	-1.5M	-1.9M	-1.5M	-647K	16K	109K	22K
Other Total Stockholders' Equity	1.1B	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	367.7M	340.1M	301.8M	286.6M	286M	308.4M	73.4M
Total Equity	367.7M	340.1M	301.8M	286.6M	286M	308.4M	73.4M
SUMMARY
Total Liabilities & Equity	720.9M	676.5M	580.3M	568.7M	440.6M	444.8M	175.9M
Total Investments	0.0	2M	0.0	0.0	0.0	0.0	0.0
Total Debt	233.1M	225.4M	174.5M	173.4M	0.0	0.0	0.0
Net Debt	-53.2M	-28.8M	-42.4M	-35.2M	-256.4M	-314.1M	-55.4M
Shares Outstanding	122,161,220	122,161,220	122,161,220	122,161,220	122,161,220	122,161,220	122,161,220

SEC Filings

WRBY - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 28, 2026	June 08, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 09, 2026	February 04, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 08, 2025	December 08, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 08, 2025	June 30, 2025	2025	View Filing

Showing 1 to 10 of 60 filings

Related Guides

Blog Categories

Continue your WRBY research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.